Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Autocrine Signaling01:01

Autocrine Signaling

47.7K
Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
47.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.4K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LIPID MAPS: Powering discovery in lipidomics.

Science signaling·2026
Same author

The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity.

Molecular oncology·2026
Same author

Pervanadate-induced oxidation relieves autoinhibition of the protein tyrosine kinase SRC.

Science signaling·2026
Same author

HIF1α gates tendon response to overload and drives tendinopathy independently of vascular recruitment.

Science translational medicine·2026
Same author

PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity.

Nature communications·2024
Same author

Concordant inter-laboratory derived concentrations of ceramides in human plasma reference materials via authentic standards.

Nature communications·2024

Related Experiment Video

Updated: Jun 7, 2025

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

4.4K

Pancreatic CAF-Derived Autotaxin Drives Autocrine CTGF Expression to Modulate Protumorigenic Signaling.

Fanny Volat1, Ragini Medhi1, Lauren Z Maggs1,2,3

  • 1Cancer Research Horizons, Cambridge, United Kingdom.

Molecular Cancer Therapeutics
|November 21, 2024
PubMed
Summary

Cancer-associated fibroblasts drive pancreatic cancer growth through autotaxin (ATX) signaling. Inhibiting ATX reduces tumor-promoting factors like CTGF, offering a new therapeutic strategy for pancreatic ductal adenocarcinoma.

More Related Videos

Experimental Generation of Carcinoma-Associated Fibroblasts CAFs from Human Mammary Fibroblasts
15:43

Experimental Generation of Carcinoma-Associated Fibroblasts CAFs from Human Mammary Fibroblasts

Published on: October 25, 2011

23.4K
Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
03:42

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models

Published on: September 27, 2024

1.3K

Related Experiment Videos

Last Updated: Jun 7, 2025

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

4.4K
Experimental Generation of Carcinoma-Associated Fibroblasts CAFs from Human Mammary Fibroblasts
15:43

Experimental Generation of Carcinoma-Associated Fibroblasts CAFs from Human Mammary Fibroblasts

Published on: October 25, 2011

23.4K
Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
03:42

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models

Published on: September 27, 2024

1.3K

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment Research

Background:

  • Autotaxin (ATX) is a target in pancreatic ductal adenocarcinoma (PDAC).
  • The ATX/lysophosphatidic acid (LPA) axis role in PDAC's tumor microenvironment (TME) is not fully understood.
  • Cancer-associated fibroblasts (CAFs) are key components of the PDAC TME.

Purpose of the Study:

  • To investigate the source and function of ATX in the PDAC TME.
  • To identify downstream mediators of ATX signaling in CAFs.
  • To explore the dual role of ATX (enzymatic and chaperone) in CAF-mediated protumorigenic signaling.

Main Methods:

  • Analysis of patient samples and cell line datasets to determine ENPP2 (ATX) expression.
  • Utilizing the ATX inhibitor IOA-289 in a PDAC CAF-derived cell line (0082T).
  • Genetic and pharmacologic inhibition of ATX in CAFs to assess CTGF secretion and LPA signaling.

Main Results:

  • The majority of ENPP2 expression in PDAC originates from the TME, particularly CAFs.
  • CAF-derived ATX promotes protumorigenic signaling through autocrine and paracrine mechanisms.
  • Inhibition of ATX in CAFs reduced connective tissue growth factor (CTGF) secretion via LPA receptor signaling.
  • Extracellular LPA levels increased upon ATX inhibition, suggesting a role for ATX's chaperone function.

Conclusions:

  • ATX, primarily from CAFs, promotes a protumorigenic PDAC microenvironment.
  • ATX influences CAF secretion through both its enzymatic (LPA production) and chaperone functions.
  • Targeting ATX offers a potential therapeutic strategy for PDAC by disrupting CAF-mediated pro-tumorigenic signaling.